QTRX · Quanterix Corp
$2.59
-0.27 (-9.44%)
At close · Aug 14
Market Cap
$122.49M
Shares
47.29M
Quanterix Corp Earnings Call Transcripts
Every quarterly earnings call for Quanterix Corp (QTRX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼3.8%
$26.65M
−$36.55M
'22 Q3
22-11-08
▼14.7%
$25.82M
−$18.20M
'22 Q4
23-03-06
▼3.7%
$28.46M
−$7.27M
'23 Q1
23-05-09
▲31.1%
$30.80M
−$5.55M
'23 Q2
23-08-07
▲18.4%
$31.56M
−$6.72M
'23 Q3
23-11-06
▲22.2%
$31.55M
−$8.81M
'23 Q4
24-02-29
▲12.7%
$32.07M
−$11.16M
'24 Q1
24-05-07
▲11.6%
$34.38M
−$7.39M
'24 Q2
24-08-08
▲13.5%
$35.81M
−$8.35M
'24 Q3
24-11-12
▼5.4%
$30.33M
−$20.50M
'25 Q1
25-05-12
▲11.4%
$35.16M
−$11.63M
'24 Q4
25-05-12
▼28.8%
$24.48M
−$30.01M
'25 Q2
25-08-07
▲12.3%
$40.23M
−$33.52M
'25 Q3
25-11-10
▲24.7%
$43.85M
−$23.12M
'25 Q4
26-03-02
▲20.1%
$36.41M
−$17.54M
'26 Q1
26-05-06
LATEST
▲34.4%
$32.91M
−$48.93M
'26 Q2
26-08-10
Conference
Investor event
2026-08-12
CG 46th Annual Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-10
Quanterix Corporation Q2 2026 Earnings Call
Cautious tone
Spatial and Simoa instruments/research tools
Diagnostics growth and Lucent AD
CMS pricing and FDA pathway
Revenue
$32.91M
▲ 34.4% YoY Diluted EPS
$-1.04
Gross margin
38.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Quanterix Corp Q1 FY2026 Earnings Call
Positive tone
Product launches and platform upgrades
Alzheimer's diagnostics growth investment
Commercial execution and sales force buildout
Revenue
$36.41M
▲ 20.1% YoY Diluted EPS
$-0.37
Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-02
Quanterix Corp Q4 FY2025 Earnings Call
Confident tone
Simoa and Spatial product lines
Alzheimer's diagnostics opportunity
Accelerator lab and pharma demand
Revenue
$43.85M*
▲ 24.7% YoY Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Quanterix Corp Q3 FY2025 Earnings Call
Positive tone
Revenue and end-market conditions
Accelerator lab services
Instrument placements and recovery
Revenue
$40.23M
▲ 12.3% YoY Diluted EPS
$-0.73
Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Quanterix Corp Q2 FY2025 Earnings Call
Positive tone
Akoya Acquisition & Integration
Cost Synergies & Path to Cash Flow Positive
Proteomics & Long-Term Market Opportunity
Revenue
$24.48M
▼ 28.8% YoY Diluted EPS
$-0.77
Gross margin
40.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-05-12
Quanterix Corp Q4 FY2024 Earnings Call
Positive tone
Revenue growth and recurring revenue
Simoa ONE platform and menu expansion
Akoya Biosciences acquisition and synergies
Revenue
$35.16M*
▲ 11.4% YoY Gross margin
63.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q1
2025-05-12
Quanterix Corp Q1 FY2025 Earnings Call
Balanced tone
Revenue and Guidance
Simoa ONE Platform
Accelerator / Pharma
Revenue
$30.33M
▼ 5.4% YoY Diluted EPS
$-0.53
Gross margin
48.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-12
Quanterix Corp Q3 FY2024 Earnings Call
Positive tone
Alzheimer's Disease Diagnostics
Neurology and Biomarker Menu Expansion
Restatement and Preliminary Results Risk
Revenue
$35.81M
▲ 13.5% YoY Diluted EPS
$-0.22
Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Quanterix Corp Q2 FY2024 Earnings Call
Revenue
$34.38M
▲ 11.6% YoY Diluted EPS
$-0.19
Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Quanterix Corp Q1 FY2024 Earnings Call
Confident tone
Quarterly revenue and consumables growth
Alzheimer's disease diagnostics and tau biomarkers
BioHermes and CANTATA clinical trials / multi-marker test
Revenue
$32.07M
▲ 12.7% YoY Diluted EPS
$-0.29
Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Quanterix Corp Q4 FY2023 Earnings Call
Confident tone
Alzheimer's diagnostics and p-Tau 217
Simoa technology platform innovation
2024 financial guidance and diagnostics spending
Revenue
$31.55M
▲ 22.2% YoY Diluted EPS
$-0.23
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Quanterix Corp Q3 FY2023 Earnings Call
Revenue
$31.56M
▲ 18.4% YoY Diluted EPS
$-0.18
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Quanterix Corp Q2 FY2023 Earnings Call
Revenue
$30.80M
▲ 31.1% YoY Diluted EPS
$-0.15
Gross margin
63.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Quanterix Corp Q1 FY2023 Earnings Call
Revenue
$28.46M
▼ 3.7% YoY Diluted EPS
$-0.19
Gross margin
56.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Quanterix Corp Q4 FY2022 Earnings Call
Revenue
$25.82M
▼ 14.7% YoY Diluted EPS
$-0.49
Gross margin
49.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Quanterix Corp Q3 FY2022 Earnings Call
Revenue
$26.65M
▼ 3.8% YoY Diluted EPS
$-0.99
Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Quanterix Corp Q2 FY2022 Earnings Call
Revenue
$23.50M
▼ 7.4% YoY Diluted EPS
$-0.73
Gross margin
35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Quanterix Corp Q1 FY2022 Earnings Call
Revenue
$29.55M
▲ 8.6% YoY Diluted EPS
$-0.49
Gross margin
47.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Quanterix Corp Q4 FY2021 Earnings Call
Revenue
$30.29M*
▲ 15.9% YoY Gross margin
63.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Quanterix Corp Q3 FY2021 Earnings Call
Revenue
$27.69M
▼ 11.8% YoY Diluted EPS
$-0.43
▼ 714.3% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Quanterix Corp Q2 FY2021 Earnings Call
Revenue
$25.37M
▲ 93.2% YoY Diluted EPS
$-0.33
Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Quanterix Corp Q1 FY2021 Earnings Call
Revenue
$27.21M
▲ 73% YoY Diluted EPS
$-0.29
Gross margin
60.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Quanterix Corp Q4 FY2020 Earnings Call
Revenue
$26.13M
▲ 64.2% YoY Diluted EPS
$-0.31
Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Quanterix Corp Q3 FY2020 Earnings Call
Revenue
$31.39M
▲ 110% YoY Diluted EPS
$0.07
Gross margin
67.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Quanterix Corp Q2 FY2020 Earnings Call
Revenue
$13.13M
▼ 3% YoY Diluted EPS
$-0.43
Gross margin
39.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Quanterix Corp Q1 FY2020 Earnings Call
Revenue
$15.73M
▲ 27.5% YoY Diluted EPS
$-0.41
Gross margin
43.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-09
Quanterix Corp Q4 FY2019 Earnings Call
Revenue
$15.92M
▲ 46.3% YoY Gross margin
43.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 earnings calls
Key facts
CIK
1503274
CUSIP
74766Q101
13F (30d)
130 filings
125 filers
Visit website
Investor relations